6-[3-[[butyl(methyl)amino]methyl]phenyl]-1-cyclobutyl-N-(oxan-4-ylmethyl)pyrazolo[5,4-b]pyridine-4-carboxamide
C29H39N5O2 — CID 162212009
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[3-[[butyl(methyl)amino]methyl]phenyl]-1-cyclobutyl-N-(oxan-4-ylmethyl)pyrazolo[5,4-b]pyridine-4-carboxamide
6-[3-[[butyl(methyl)amino]methyl]phenyl]-1-cyclobutyl-N-(oxan-4-ylmethyl)pyrazolo[5,4-b]pyridine-4-carboxamide (PubChem CID 162212009) has the molecular formula C29H39N5O2 and a molecular weight of 489.66 g/mol. Its IUPAC name is 6-[3-[[butyl(methyl)amino]methyl]phenyl]-1-cyclobutyl-N-(oxan-4-ylmethyl)pyrazolo[5,4-b]pyridine-4-carboxamide.
Molecular Properties
| Compound Name | 6-[3-[[butyl(methyl)amino]methyl]phenyl]-1-cyclobutyl-N-(oxan-4-ylmethyl)pyrazolo[5,4-b]pyridine-4-carboxamide |
|---|---|
| PubChem CID | 162212009 |
| Molecular Formula | C29H39N5O2 |
| Molecular Weight | 489.66 g/mol |
| Exact Mass | 489.31 |
| IUPAC Name | 6-[3-[[butyl(methyl)amino]methyl]phenyl]-1-cyclobutyl-N-(oxan-4-ylmethyl)pyrazolo[5,4-b]pyridine-4-carboxamide |
| SMILES | CCCCN(C)Cc1cccc(-c2cc(C(=O)NCC3CCOCC3)c3cnn(C4CCC4)c3n2)c1 |
| InChI | InChI=1S/C29H39N5O2/c1-3-4-13-33(2)20-22-7-5-8-23(16-22)27-17-25(29(35)30-18-21-11-14-36-15-12-21)26-19-31-34(28(26)32-27)24-9-6-10-24/h5,7-8,16-17,19,21,24H,3-4,6,9-15,18,20H2,1-2H3,(H,30,35) |
| InChIKey | ZSYWQVWSXNKXLE-UHFFFAOYSA-N |
| XLogP | 5.21 |
| TPSA | 72.28 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 489.66 |
| LogP ≤ 5 | 5.21 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162212009 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.